Showing results (191-200 of 251) with videos related to

Sort By:
Pageof 26
Acta Neuropathologica Communications|November 14, 2025
Rotenone targets midbrain astrocytes to produce glial dysfunction-mediated dopaminergic neurodegenerationIkuko Miyazaki, Nami Isooka, Ryo Kikuoka, et al.
Developmental Neurobiology|June 15, 2007
Reconstruction of dopaminergic neural network and locomotion function in planarian regeneratesKaneyasu Nishimura, Yoshihisa Kitamura, Takeshi Inoue, et al.
Neurochemistry International|August 4, 2009
Neuroprotective effect of the antiparkinsonian drug pramipexole against nigrostriatal dopaminergic degeneration in rotenone-treated miceMasatoshi Inden, Yoshihisa Kitamura, Aya Tamaki, et al.
Currents in Pharmacy Teaching & Learning|May 23, 2025
The educational effect of incorporating an online context into medication instruction training in clinical preparation educationSusumu Kawano, Hiroaki Kaji, Yasuhisa Izushi, et al.
The Journal of Biological Chemistry|October 16, 2010
Galantamine-induced amyloid-{beta} clearance mediated via stimulation of microglial nicotinic acetylcholine receptorsKazuyuki Takata, Yoshihisa Kitamura, Mana Saeki, et al.
Journal of Pharmacological Sciences|March 12, 2009
Protection against oxidative stress-induced neurodegeneration by a modulator for DJ-1, the wild-type of familial Parkinson's disease-linked PARK7Takashi Yanagida, Yoshihisa Kitamura, Koichiro Yamane, et al.
Neuroscience Research|October 11, 2008
Synergistic effect of galantamine on nicotine-induced neuroprotection in hemiparkinsonian rat modelTakashi Yanagida, Hiroki Takeuchi, Yoshihisa Kitamura, et al.
European Journal of Pharmacology|April 27, 2007
Effects of imipramine on extracellular serotonin and noradrenaline concentrations in ACTH-treated ratsYoshihisa Kitamura, Kozue Akiyama, Shinji Hashimoto, et al.
Scientific Reports|November 27, 2020
Mirtazapine exerts astrocyte-mediated dopaminergic neuroprotectionRyo Kikuoka, Ikuko Miyazaki, Natsuki Kubota, et al.
Pageof 26